These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 14648234

  • 1. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
    Attallah AM, Tabll AA, El-Sadany M, Ibrahim TA, El-Dosoky I.
    Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
    [Abstract] [Full Text] [Related]

  • 2. Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.
    Marafin C, Rinaldi M, Angonese C, De Franchis G, Plebani M, Naccarato R, Farinati F.
    Ital J Gastroenterol; 1996 Dec; 28(9):493-8. PubMed ID: 9131393
    [Abstract] [Full Text] [Related]

  • 3. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K, Thepthai C, Lamchiagdhase P, Lerdwana S, Tachavanich K, Thanomsuk P, Wanachiwanawin W, Fucharoen S, Darden JM.
    Cytometry; 2000 Feb 15; 42(1):11-7. PubMed ID: 10679738
    [Abstract] [Full Text] [Related]

  • 4. [Identification of immunological effector cells after autologous cytokine-induced killer cells treatment and its clinical implication in hepatocellular carcinoma patients].
    Shi M, Zhang B, Tang ZR, Lei ZY, Wang HF, Feng YY, Liu JC, Fan ZP, Li HW, Mu JS, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2049-53. PubMed ID: 14703414
    [Abstract] [Full Text] [Related]

  • 5. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M, Sakaguchi Y, Nakamura M, Sutani T, Tsuruta S, Kato S, Uemura S, Nishida Y, Hashimoto T, Kagoshima T.
    J Cardiol; 1995 Aug 10; 26(2):69-79. PubMed ID: 7674146
    [Abstract] [Full Text] [Related]

  • 6. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD, Patel J, Schwab H, Martinez J.
    Cytometry B Clin Cytom; 2003 Sep 10; 55(1):22-8. PubMed ID: 12949956
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
    Laso FJ, Madruga JI, López A, Ciudad J, Alvarez-Mon M, San Miguel J, Orfao A.
    Alcohol Clin Exp Res; 1997 Jun 10; 21(4):672-6. PubMed ID: 9194923
    [Abstract] [Full Text] [Related]

  • 8. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V.
    Bull Cancer; 2008 Nov 10; 95(11):1029-38. PubMed ID: 19036674
    [Abstract] [Full Text] [Related]

  • 9. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.
    Gastroenterology; 2007 Jun 10; 132(7):2328-39. PubMed ID: 17570208
    [Abstract] [Full Text] [Related]

  • 10. [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B].
    Zou ZS, Xu DP, Li BS, Huang L, Fu JL, Zhang Z, Jin L, Liu QF, Zhang H, Xin SJ, Wang FS.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2416-9. PubMed ID: 18036321
    [Abstract] [Full Text] [Related]

  • 11. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y.
    J Hepatol; 2006 Aug 11; 45(2):254-62. PubMed ID: 16600416
    [Abstract] [Full Text] [Related]

  • 12. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
    Zhou QM, Wu PH, Zhao M, Wang QJ, Huang LX, Li YQ, Chen SP, Xia JC.
    Ai Zheng; 2006 Nov 11; 25(11):1414-8. PubMed ID: 17094912
    [Abstract] [Full Text] [Related]

  • 13. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
    Lu W, Li YH, He XF, Chen Y, Zeng QL, Qiu YR.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun 11; 22(6):524-6. PubMed ID: 12297475
    [Abstract] [Full Text] [Related]

  • 14. CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma.
    Nakao M, Sata M, Saitsu H, Yutani S, Kawamoto M, Kojiro M, Itoh K.
    Cell Immunol; 1997 May 01; 177(2):176-81. PubMed ID: 9178645
    [Abstract] [Full Text] [Related]

  • 15. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.
    Hirofuji H, Kakumu S, Fuji A, Ohtani Y, Murase K, Tahara H.
    Clin Exp Immunol; 1987 May 01; 68(2):348-56. PubMed ID: 2820634
    [Abstract] [Full Text] [Related]

  • 16. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T, Nagai H, Sumino Y, Miki K.
    Cancer Chemother Pharmacol; 2008 Aug 01; 62(3):401-6. PubMed ID: 17932673
    [Abstract] [Full Text] [Related]

  • 17. Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma.
    Liu Y, Poon RT, Hughes J, Feng X, Yu WC, Fan ST.
    Clin Immunol; 2005 Feb 01; 114(2):174-82. PubMed ID: 15639651
    [Abstract] [Full Text] [Related]

  • 18. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V, Parisi G, Spadaro A, Scrivo R, Barone F, Moretti T, Bernardini G, Strom R, Taccari E, Valesini G.
    J Rheumatol; 2005 Feb 01; 32(2):283-6. PubMed ID: 15693088
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma.
    Kakumu S, Hirofuji H, Fuji A, Tahara H, Yoshioka K.
    J Clin Lab Immunol; 1988 May 01; 26(1):29-32. PubMed ID: 2846843
    [Abstract] [Full Text] [Related]

  • 20. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X.
    J Gastroenterol Hepatol; 2011 Oct 01; 26(10):1519-26. PubMed ID: 21557772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.